Shanghai Fosun Pharmaceutical Group Co Ltd (600196) — Cash Flow-to-Debt Ratio
Shanghai Fosun Pharmaceutical Group Co Ltd (600196) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of CN¥2.40 Billion could theoretically repay 0% of its total liabilities (CN¥57.97 Billion) in one year. See how much free cash does Shanghai Fosun Pharmaceutical Group Co L generate to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Shanghai Fosun Pharmaceutical Group Co Ltd Cash Flow-to-Debt Ratio (1998–2025)
Historical debt coverage capacity for Shanghai Fosun Pharmaceutical Group Co Ltd across 28 annual periods. Also explore 600196 year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Shanghai Fosun Pharmaceutical Group Co Ltd (1998–2025)
Year-by-year debt coverage analysis for Shanghai Fosun Pharmaceutical Group Co Ltd. For market capitalisation and broader financial context, see Shanghai Fosun Pharmaceutical Group Co L market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | CN¥6.01 Billion | CN¥57.97 Billion | ▲ +33.1% |
| 2024 | 0.08x | CN¥4.48 Billion | CN¥57.53 Billion | ▲ +1.4% |
| 2023 | 0.08x | CN¥4.36 Billion | CN¥56.85 Billion | ▼ -3.5% |
| 2022 | 0.08x | CN¥4.22 Billion | CN¥53.05 Billion | ▼ -9.6% |
| 2021 | 0.09x | CN¥3.95 Billion | CN¥44.92 Billion | ▲ +28.5% |
| 2020 | 0.07x | CN¥2.58 Billion | CN¥37.70 Billion | ▼ -21.6% |
| 2019 | 0.09x | CN¥3.22 Billion | CN¥36.92 Billion | ▲ +9.4% |
| 2018 | 0.08x | CN¥2.95 Billion | CN¥36.96 Billion | ▼ -0.3% |
| 2017 | 0.08x | CN¥2.58 Billion | CN¥32.23 Billion | ▼ -29.7% |
| 2016 | 0.11x | CN¥2.11 Billion | CN¥18.52 Billion | ▲ +23.2% |
| 2015 | 0.09x | CN¥1.62 Billion | CN¥17.53 Billion | ▲ +25.1% |
| 2014 | 0.07x | CN¥1.20 Billion | CN¥16.23 Billion | ▼ -13.7% |
| 2013 | 0.09x | CN¥1.01 Billion | CN¥11.81 Billion | ▲ +31.3% |
| 2012 | 0.07x | CN¥665.52 Million | CN¥10.20 Billion | ▲ +125.0% |
| 2011 | 0.03x | CN¥316.65 Million | CN¥10.92 Billion | ▲ +5.9% |
| 2010 | 0.03x | CN¥203.36 Million | CN¥7.43 Billion | ▼ -52.2% |
| 2009 | 0.06x | CN¥261.87 Million | CN¥4.58 Billion | ▼ -24.0% |
| 2008 | 0.08x | CN¥233.04 Million | CN¥3.09 Billion | ▲ +78.7% |
| 2007 | 0.04x | CN¥131.48 Million | CN¥3.12 Billion | ▼ -31.9% |
| 2006 | 0.06x | CN¥184.91 Million | CN¥2.99 Billion | ▼ -8.1% |
| 2005 | 0.07x | CN¥188.35 Million | CN¥2.79 Billion | ▼ -22.5% |
| 2004 | 0.09x | CN¥205.10 Million | CN¥2.36 Billion | ▲ +27.6% |
| 2003 | 0.07x | CN¥150.14 Million | CN¥2.20 Billion | ▼ -2.4% |
| 2002 | 0.07x | CN¥102.47 Million | CN¥1.47 Billion | ▼ -9.3% |
| 2001 | 0.08x | CN¥68.15 Million | CN¥884.68 Million | ▼ -80.4% |
| 2000 | 0.39x | CN¥138.43 Million | CN¥352.61 Million | ▲ +106.7% |
| 1999 | 0.19x | CN¥38.20 Million | CN¥201.15 Million | ▼ -66.8% |
| 1998 | 0.57x | CN¥66.55 Million | CN¥116.36 Million | — |